1. Fisher SJ, Roberts JM . Defects in placentation and placental perfusion. In: Lindheimer MD, Roberts JM. Cunningham FG, Appleton and Lange (eds). Chelsey's Hypertensive Disorders in Pregnancy 2nd (edn) 1999, 377–394.
2. WHO 2004, Bethesda, MD Global Burden of Disease for the Year 2001 by World Bank Region, for Use in Disease Control Priorities in Developing Countries, National Institutes of Health: WHO. Make every mother and child count. In: World Health Report 2005. World Health Organization: WHO: Geneva.
3. Maynard SE, Moore Simas TA, Solitro MJ, Rajan A, Crawford S, Soderland P, Meyer BA . Circulating angiogenic factors in singleton vs multiple-gestation pregnancies. Am J Obstet Gynecol 2008; 198: 201–207.
4. Karumanchi SA, Bdolah Y . Hypoxia and sFlt-1 in preeclampsia: the ‘chicken-and-egg’ question. Endocrinology 2004; 145: 4838–4845.
5. Ye YH, Liu L, Zhan Y, Peng W . Predictive value of serum soluble fms-like tyrosine kinase 1 concentration in preeclampsia at second trimester. Zhonghua Fu Chan Ke Za Zhi 2006; 41: 433–435.